Journal of Glycobiology
Open Access

Glycans in Stem Cell Biology: Implications for Regenerative Medicine and Disease Treatment

Clodagh Sadhbh^{* *}Correspondence: Clodagh Sadhbh, Department of Chemistry, University of Galway, Galway, Ireland, Email:

Author info »

Description

Stem cells, with their ability to self-renew and differentiate into multiple cell types, hold significant potential for regenerative medicine and the treatment of various diseases. In recent years, glycobiology the study of glycans (sugar chains) and their biological roles has emerged as a key area of interest in stem cell biology. Glycans, attached to proteins and lipids, regulate numerous cellular processes, including stem cell self-renewal, differentiation, migration, and adhesion. This short communication highlights the role of glycans in stem cell biology and their implications for advancing regenerative therapies and disease treatments.

Glycans and stem cell function

Glycans are crucial in regulating stem cell behaviors. For instance, the glycosylation of cell surface proteins such as Notch receptors and Wnt signaling molecules plays an important role in controlling stem cell differentiation and self-renewal [1]. Glycosylation of cell adhesion molecules like integrins and cadherins also mediates stem cell interactions with the Extracellular Matrix (ECM) and other cells within the stem cell niche, influencing stem cell fate decisions [2]. Notably, sialylation and heparin sulfate glycosylation have been shown to modulate stem cell signaling pathways such as Fibroblast Growth Factor (FGF) and Hedgehog signaling, important for maintaining stem cell properties [3].

Alterations in glycosylation patterns can affect stem cell behavior. For example, decreased sialylation on stem cells can disrupt their differentiation potential, contributing to diseases such as neurodegenerative disorders [4]. Additionally, fucosylation and O-glycosylation are implicated in the regulation of stem cell migration and homing, essential for tissue repair [5].

Glycans and stem cell migration

One of the challenges in regenerative medicine is ensuring the successful migration of stem cells to injury sites. Glycans play a critical role in this process by mediating stem cell interactions with endothelial cells and the ECM, which guide stem cell trafficking. For example, selectins and E-selectin ligands on stem cells are involved in the early stages of migration and homing to tissues [6]. Moreover, glycosylated integrins contribute to the adhesion and migration of stem cells through ECM components [7]. Manipulating these glycan-mediated interactions can improve stem cell homing and engraftment, a crucial aspect of tissue regeneration and repair.

Implications for regenerative medicine

The therapeutic potential of glycans in stem cell biology is evident in tissue engineering and cell therapy. By modifying glycosylation patterns, researchers aim to enhance stem cell homing, differentiation, and integration into damaged tissues. For example, glycomimetics synthetic molecules that mimic the structure of natural glycans have shown potential in modulating stem cell migration and adhesion [8]. In addition, glycosylation-modifying enzymes can be used to adjust glycan profiles on stem cells, optimizing their function in regenerative therapies [9]. Furthermore, the development of glycan-based biomaterials that support stem cell growth and differentiation is an emerging field in tissue engineering. These materials can be designed to mimic native ECM glycan structures, creating a more favorable environment for stem cells [10].

Glycans in disease treatment

Aberrant glycosylation patterns are linked to a range of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. In cancer, altered glycosylation of cancer stem cells promotes their ability to evade immune surveillance, resist chemotherapy, and metastasize. In neurodegenerative diseases, changes in glycosylation affect neural stem cell differentiation and their capacity for tissue repair. Understanding how glycosylation influences disease pathogenesis opens the door to novel therapeutic approaches targeting these glycan alterations.

Conclusion

Glycans are critical regulators of stem cell behavior, influencing processes such as differentiation, migration, and tissue integration. Understanding the role of glycans in stem cell biology provides valuable insights into enhancing regenerative therapies and developing novel treatments for diseases. By targeting glycosylation pathways, it may be possible to optimize stem cell-based therapies, improving tissue regeneration and offering potential solutions for a wide range of medical conditions.

References

1. Alghazali R, Nugud A, El-Serafi A. Glycan modifications as regulators of stem cell fate. Biology. 2024;13(2):76.

   [Crossref] [Google Scholar] [Pubmed]

2. Russo L, Cipolla L. Glycomics: New challenges and opportunities in regenerative medicine. Chemistry. 2016;22(38):13380-13388.

   [Crossref] [Google Scholar] [Pubmed]

3. Du J, Yarema KJ. Carbohydrate engineered cells for regenerative medicine. Adv Drug Deliv Rev. 2010;62(7-8):671-682.

   [Crossref] [Google Scholar] [Pubmed]

4. Miyoshi E. Regenerative medicine and glycans. Glycoforum. 2020;23:A9.

   [Crossref] [Google Scholar]

5. Guizzardi R, Vacchini M, Cipolla L. Carbohydrates in regenerative medicine: From scaffolds to cell fate modulators. Regenerative Medicine and Plastic Surgery: Elements, Research Concepts and Emerging Technologies. 2019:129-149.

   [Crossref] [Google Scholar]

6. Mikami T, Kitagawa H. Sulfated glycosaminoglycans: Their distinct roles in stem cell biology. Glycoconj J. 2017;34:725-735.

   [Crossref] [Google Scholar] [Pubmed]

7. Heiskanen A, Hirvonen T, Salo H, Impola U, Olonen A, Laitinen A, et al. Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J. 2009;26:367-384.

   [Crossref] [Google Scholar] [Pubmed]

8. Hirvonen T, Suila H, Kotovuori A, Ritamo I, Heiskanen A, Sistonen P, et al. The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev. 2012;21(3):455-464.

   [Crossref] [Google Scholar] [Pubmed]

9. Desantis S, Accogli G, Crovace A, Francioso EG, Crovace AM. Surface glycan pattern of canine, equine, and ovine bone marrow‐derived mesenchymal stem cells. Cytometry A. 2018;93(1):73-81.

   [Crossref] [Google Scholar] [Pubmed]

10. Muthana SM, Campbell CT, Gildersleeve JC. Modifications of glycans: Biological significance and therapeutic opportunities. ACS Chem Biol. 2012;7(1):31-43.

    [Crossref] [Google Scholar] [Pubmed]